genedrive (LON:GDR) Trading 10% Higher – Here’s Why

genedrive plc (LON:GDR)’s share price was up 10% during mid-day trading on Wednesday . The company traded as high as GBX 0.88 and last traded at GBX 0.88. Approximately 4,591,832 shares changed hands during trading, a decline of 76% from the average daily volume of 18,979,752 shares. The stock had previously closed at GBX 0.80.

genedrive Stock Up 12.5%

The firm’s 50-day moving average price is GBX 0.87 and its 200 day moving average price is GBX 0.89. The company has a market capitalization of £9.27 million, a price-to-earnings ratio of -0.42 and a beta of -0.04. The company has a current ratio of 4.60, a quick ratio of 5.52 and a debt-to-equity ratio of 0.35.

genedrive Company Profile

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.